Teladoc Health Inc Stock Price, News & Analysis

Teladoc Health (NYSE:TDOC) has granted restricted stock unit (RSU) awards to two new non-executive employees as employment inducement awards. The awards, effective June 1, 2025, cover a total of 80,000 shares of Teladoc's common stock. The RSUs have a vesting schedule where one-third vests after the first year, with the remaining two-thirds vesting quarterly over the following two years. These awards were approved by the company's Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to five new employees. Four employees from the recently acquired Uplift Health Technologies received restricted stock units totaling 215,028 shares, vesting over two or three years based on continued service. Additionally, a new non-executive employee was granted 52,300 restricted stock units, with one-third vesting on the first anniversary and the remainder vesting quarterly over two years.

These awards were approved by Teladoc's Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Teladoc Health reported mixed Q1 2025 financial results, with revenue declining 3% year-over-year to $629.4 million. The company posted a net loss of $93.0 million ($0.53 per share), including a $59.1 million goodwill impairment charge.

The Integrated Care segment showed positive growth, with revenue up 3% to $389.5 million and improved EBITDA margin of 12.9%. However, BetterHelp segment revenue decreased 11% to $239.9 million with an EBITDA margin of 3.2%.

Key highlights include the acquisition of UpLift Health Technologies for $30 million plus potential earnout of $15 million, expanding mental health coverage to over 100 million lives. The company's outlook for 2025 projects full-year revenue between $2.47-2.58 billion and adjusted EBITDA of $263-304 million, reflecting continued challenges in the BetterHelp segment but stability in Integrated Care operations.

Teladoc Health has acquired UpLift, a virtual mental health services provider, in a $30 million all-cash deal with potential additional earnout of $15 million. UpLift, which generated approximately $15 million in revenue in 2024, brings access to over 100 million covered lives through health plan relationships and a network of 1,500+ mental health professionals.

The acquisition enables BetterHelp, Teladoc's consumer therapy division, to accept insurance benefits while expanding mental healthcare accessibility. UpLift will maintain its existing leadership under CEO Kyle Talcott and continue managing its provider network, quality oversight, and insurance administration.

This strategic move strengthens Teladoc's position in virtual mental health services, complementing its Integrated Care segment which delivered nearly one million mental health visits in 2024. The transaction closed on April 30, 2025, with UpLift's results to be included in BetterHelp's reporting segment.

Teladoc Health (NYSE: TDOC), the global leader in virtual care, has scheduled its first quarter 2025 financial results announcement for Wednesday, April 30, 2025, after market close. The company will host a conference call at 4:30 p.m. ET the same day to review the results.

Participants can join via phone by dialing 1-833-470-1428 (U.S.) with access code #309585. International dial-in numbers are available through a dedicated link. A live audio webcast will be accessible at the company's investor relations website, with a replay available for approximately 90 days after the call.

Teladoc Health (NYSE: TDOC) has launched its next generation Cardiometabolic Health Program aimed at improving population health and preventing the progression of diabetes, hypertension, and obesity. The program focuses on nine key health factors: diet, physical activity, sleep, stress management, weight, blood lipids, blood glucose, blood pressure, and nicotine exposure.

New features include:

• BetterSleep premium app subscription
• Access to registered dietitians
• Proactive health coaching
• At-home testing for cardiometabolic measures
• Dynamic health insights from connected devices
• Integration with Teladoc's 24/7 care services

The program has demonstrated strong results, with 58% of participants in the diabetes management program achieving remission-level A1c, and 88% of hypertension program participants improving or maintaining blood pressure after one year. Teladoc Health is backing the program's effectiveness by putting 100% of program fees at risk.

Teladoc Health (NYSE: TDOC) has formed a strategic partnership with Carrum Health to integrate Centers of Excellence (COE) specialty care services into their platform. The collaboration enables seamless referrals from Teladoc providers to Carrum's nationwide network of vetted healthcare providers through Teladoc's Connected Care program.

The partnership addresses employer concerns about managing multiple point solutions, with 70% of employers worried about lack of coordination between healthcare services. With over 93 million members, Teladoc Health will offer single sign-on access through their unified app, allowing eligible members to access Carrum's surgical care, cancer care, and substance use treatment services.

The integration aims to streamline administration, improve member engagement, and deliver cost savings for employers amid rising healthcare costs, with PwC predicting an 8% increase in healthcare costs in 2025.

Teladoc Health (NYSE: TDOC) has announced an expansion of its connected care partnerships across new care categories. The company is integrating new digital health partners into its Prism care platform, including services for digestive health, centers of excellence, fertility, and family building.

Key new partnerships include:

• Carrot Fertility for fertility, family building, and hormonal health support
• Carrum Health for specialty care centers of excellence
• Cylinder Health for digestive health, showing 13% engagement
• Oshi Health for virtual GI care with ROI guarantee

The expansion addresses growing demand for integrated virtual care solutions, with over 70% of large employers concerned about siloed care experiences. Teladoc Health, serving more than 93 million members, offers streamlined contracting and administration through its unified app with single sign-on capabilities.

Teladoc Health (NYSE: TDOC) has announced a pharmacy integration partnership with Gifthealth, Eli Lilly's LillyDirect pharmacy partner, to provide self-pay access to FDA-approved Zepbound® (tirzepatide) for members enrolled in its Comprehensive Weight Care Program who lack GLP-1 insurance coverage.

The integration will enable eligible Teladoc Health members to receive prescribed Zepbound® directly at home, with the company's care teams maintaining full visibility of the fulfillment process. The program includes:

• Multi-disciplinary support from licensed clinicians trained in obesity medicine
• Access to registered dietitians and health coaches
• A connected digital scale
• Personalized lifestyle coaching
• Nutrition counseling
• Mental health support
• Behavior change resources